Atlas Trials

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Clinical trial NCT03581786 · COMPLETED

Trial details

NCT number
NCT03581786
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent or Metastatic NPC
Start date
2018-10-18
Primary completion
2020-05-30
Enrollment
289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.